TAG - Emergent Technologies: Moving Bioscience to Product
Submitted by akleineb on Mon, 02/18/2008 - 9:40am.
02/29/2008 - 7:00am
02/29/2008 - 8:30am
Biotech is a complex area that doesn’t quite fit the traditional High Tech commercialization model. Come to the TAG meeting on Friday, February 29th to hear Tommy Harlan, CEO of Emergent Technologies, describe how his company addresses the chasm between scientist and market in an integrated way and what kinds of medical advances this approach is unlocking. The breakfast meeting is at 7 a.m. at The Austin Club, 110 East 9th.
RSVP at http://www.tagaustin.org/html/reservation_form.htm
TAG Background In the last entrepreneurial wave, the technology sought out the market, the executive talent, and the funding. The source for “High Tech” usually came from the technology trained and experienced population. Commercialization of “Ultra Tech” - biotech, nanotech, and informatics - will be different. Time to market, global science sources and market, and extremely more complex technology require that technology be picked when its science is turning ripe using an innovative, integrated, inclusive process.
TAG Speaker Bio
Thomas A. Harlan is the founder, President and CEO of ETI. He has participated as a principal or consultant in virtually every phase of early-stage ventures and since 1999 while at ETI has managed 14 life sciences companies from technologies licensed from The University of Oklahoma, Texas Tech University, Texas Tech School of Pharmacy, and The University of Texas at Austin.
Is this free or is there an admission charge?
Breakfast is $20 with reservations ($18 if prepaid before reservation deadline) and $25 without reservations. Reservation deadline is 5:30 p.m. Wednesday the 27th.
Sorry, I'm a newbie to this.
That's ok, thanks!